Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EF

(MedPage Today) -- BARCELONA -- With a major win in DELIVER, dapagliflozin (Farxiga) closed the gap on the types of heart failure (HF) proven to be treated safely by SGLT2 inhibition. People with HF with preserved (HFpEF) and mildly reduced...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news